Who is sponsoring NCT02690298?

NCT02690298 is sponsored by Respiratory Motion, Inc..

What drugs are being tested in NCT02690298?

Interventions in NCT02690298: ExSpiron.

What condition does NCT02690298 study?

NCT02690298 studies Non-Invasive Respiratory Volume Monitoring.

Is NCT02690298 still recruiting?

NCT02690298 is currently completed. Last updated 28 August 2018.

Last reviewed 2018-08-28 · How we verify

NCT02690298: RMI UVU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of ExSpiron™ Measurements Derived Without Patient Specific Calibration

Completed Last updated 28 August 2018

What this trial tests

trial testing ExSpiron in Non-Invasive Respiratory Volume Monitoring in 15 participants. Completed in 30 April 2016.

Timeline

1 September 2015

Primary endpoint
30 April 2016

30 April 2016

Quick facts

Lead sponsor	Respiratory Motion, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	15
Start date	1 September 2015
Primary completion	30 April 2016
Estimated completion	30 April 2016

Drugs / interventions tested

ExSpiron

Conditions studied

Non-Invasive Respiratory Volume Monitoring — all drugs for Non-Invasive Respiratory Volume Monitoring →

Sponsor

Respiratory Motion, Inc.

Who can join

Adults 21 to 90, any sex, with Non-Invasive Respiratory Volume Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Previous studies have shown that the ExSpiron™ can provide non-invasive, real-time, accurate measurements of minute ventilation (MV), tidal volume (TV) and respiratory rate (RR) after calibration with a spirometer. The purpose of this study is to compare the MV, TV and RR values measured by the ExSpiron™ without prior spirometer calibration to values obtained with a spirometer calibration. In this study, the MV and TV values will be compared between the ExSpiron™ with and without prior patient-specific calibration of the ExSpiron™ to a spirometer

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02690298 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Respiratory Motion, Inc.
Last refreshed: 28 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02690298.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing